Mrs Jennifer Hinchley, MSN, APRN, FNP-C | |
329 Remington Blvd Ste 205, Bolingbrook, IL 60440-5817 | |
(630) 226-1130 | |
Not Available |
Full Name | Mrs Jennifer Hinchley |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 6 Years |
Location | 329 Remington Blvd Ste 205, Bolingbrook, Illinois |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164988960 | NPI | - | NPPES |
W243573338 | Other | IL | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | 209018835 (Illinois) | Secondary |
363L00000X | Nurse Practitioner | 209018835 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Advocate Good Samaritan Hospital | Downers grove, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Gateway Spine And Pain Physicians Llc | 6507941598 | 4 |
News Archive
The California Nurses Association/National Nurses United today blasted the state agency that oversees public employee relations for its active collusion with University of California hospital officials in seeking to suppress the democratic rights of registered nurses, and charged the UC hospital system with employing unfair market competition with other corporate hospital chains in its attacks on UC RNs.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced key findings from preclinical studies of the Company's novel cancer metabolism inhibitor (CMI), MPC-9528, at the Cancer and Metabolism Pathways to the Future Symposium in Edinburgh, Scotland.
Australian researchers believe they have discovered a group of cells that trigger autoimmune disease, as well as the molecular 'trigger guard' that normally holds them in check.
A team of engineers and students at the University of Rhode Island has developed an advanced blood-testing technology that incorporates a smartphone application, a hand-held biosensor and a credit card-sized cartridge to provide rapid, accurate biological analysis and wireless communication of test results.
Kaiser Health News looks at sections of a new book, Landmark: The Inside Story of America's New Health Care Law and What It Means for Us All, in which the staff of The Washington Post writes about various provisions of the new health law.
› Verified 3 days ago
Entity Name | Gateway Spine And Pain Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104013473 PECOS PAC ID: 6507941598 Enrollment ID: O20080314000583 |
News Archive
The California Nurses Association/National Nurses United today blasted the state agency that oversees public employee relations for its active collusion with University of California hospital officials in seeking to suppress the democratic rights of registered nurses, and charged the UC hospital system with employing unfair market competition with other corporate hospital chains in its attacks on UC RNs.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced key findings from preclinical studies of the Company's novel cancer metabolism inhibitor (CMI), MPC-9528, at the Cancer and Metabolism Pathways to the Future Symposium in Edinburgh, Scotland.
Australian researchers believe they have discovered a group of cells that trigger autoimmune disease, as well as the molecular 'trigger guard' that normally holds them in check.
A team of engineers and students at the University of Rhode Island has developed an advanced blood-testing technology that incorporates a smartphone application, a hand-held biosensor and a credit card-sized cartridge to provide rapid, accurate biological analysis and wireless communication of test results.
Kaiser Health News looks at sections of a new book, Landmark: The Inside Story of America's New Health Care Law and What It Means for Us All, in which the staff of The Washington Post writes about various provisions of the new health law.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Jennifer Hinchley, MSN, APRN, FNP-C 329 Remington Blvd Ste 205, Bolingbrook, IL 60440-5817 Ph: (630) 226-1130 | Mrs Jennifer Hinchley, MSN, APRN, FNP-C 329 Remington Blvd Ste 205, Bolingbrook, IL 60440-5817 Ph: (630) 226-1130 |
News Archive
The California Nurses Association/National Nurses United today blasted the state agency that oversees public employee relations for its active collusion with University of California hospital officials in seeking to suppress the democratic rights of registered nurses, and charged the UC hospital system with employing unfair market competition with other corporate hospital chains in its attacks on UC RNs.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced key findings from preclinical studies of the Company's novel cancer metabolism inhibitor (CMI), MPC-9528, at the Cancer and Metabolism Pathways to the Future Symposium in Edinburgh, Scotland.
Australian researchers believe they have discovered a group of cells that trigger autoimmune disease, as well as the molecular 'trigger guard' that normally holds them in check.
A team of engineers and students at the University of Rhode Island has developed an advanced blood-testing technology that incorporates a smartphone application, a hand-held biosensor and a credit card-sized cartridge to provide rapid, accurate biological analysis and wireless communication of test results.
Kaiser Health News looks at sections of a new book, Landmark: The Inside Story of America's New Health Care Law and What It Means for Us All, in which the staff of The Washington Post writes about various provisions of the new health law.
› Verified 3 days ago